DEMANT Demant A/S

50.63USD345.00 DKK · CPH+0.06%Mkt Cap: 10.68B USDP/E: 30.05

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hea…

Key Statistics

Company
Market Cap10.68B USD
Enterprise Value13.45B USD
Revenue (TTM)3.61B USD
Gross Profit2.55B USD
Net Income (TTM)226.71M USD
Revenue/Share17.13 USD
Last Price50.63 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees26.6K
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0060738599
Valuation
P/E (Trailing)30.05
P/E (Forward)19.81
PEG1.25
EV/EBITDA18.44
EV/Revenue3.72
P/S2.95
P/B6.48
EPS (TTM)1.68 USD
EPS (Forward)2.56 USD
52W Range
25.6881% of range56.64
52W High56.64 USD
52W Low25.68 USD
Profitability
Gross Margin75.62%
Oper. Margin17.20%
EBITDA Margin20.19%
Profit Margin6.73%
ROE15.70%
ROA3.95%
ROIC10.13%
ROCE12.40%
Growth
Revenue Growth14.80%
Earnings Growth6.40%
Cash Flow & Leverage
Operating CF565.25M USD
CapEx (TTM)125.76M USD
FCF Margin15.26%
FCF Yield5.17%
Net Debt2.76B USD
Net Debt/EBITDA3.78
Net Debt/FCF5.00
Balance Sheet
Debt/Equity2.13
Current Ratio0.82
Quick Ratio0.53
Book Value/Sh7.82 USD
Cash/Share1.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 26, 2000
Pay Date—
Splits
Last Split5:1
Split DateMay 25, 2016
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)52.80 USD
Upside (mean)+4.3%
Target Range38.15 USD – 63.10 USD
38.15+4.3% to mean63.10
# Analysts20
Ownership
Shares Out.210.90M
Float83.83M
Insiders60.00%
Institutions18.77%
Technical
SMA 5049.68 (+1.9%)
SMA 20038.57 (+31.3%)
Beta0.71
S&P 52W Chg12.00%
Avg Vol (30d)404.48K
Avg Vol (10d)568.30K
Technical Indicators
RSI (14)43.6
MACD1.0654
MACD Signal5.8879
MACD Hist.-4.8225
BB Upper56.56 USD
BB Middle53.05 USD
BB Lower49.54 USD
BB Width13.24%
ATR (14)1.360 USD
Vol Ratio (20d)0.69x

About Demant (CPH: DEMANT)

›

Demant (CPH: DEMANT) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 26,616 employees.

The shares were at 345.00 DKK on 19 November 2026, up 55.4% over 52 weeks. Its 52-week range is 175.00 DKK to 386.00 DKK: the price is 10.6% below the high and 97.1% above the low.

At a market capitalisation of 72.76B DKK, it trades at 30.1 times trailing earnings and 19.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.4, a premium of 18% for DEMANT.

Demant reports return on equity of 15.7%, an operating margin of 17.2% and revenue up 14.8% year over year.

Its debt exceeds its cash by 18.79B DKK, a debt-to-equity ratio of 2.13. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 359.85 DKK is 4.3% above the current price. The next earnings report is expected on 2 February 2027.